Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Filings indexed 913 across all filing types
Latest filing 2023-01-15 Interim / Quarterly Rep…
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Monthly Activities/Appendix 4C Cash Flow Report 7 pages 607.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "Quarterly Report for the period ending 31 December 2022" and contains detailed financial and operational updates for that quarter. It includes financial highlights such as revenue, cash receipts, cash flow from operating activities, and investments. It also contains an Appendix 4C Quarterly cash flow report, which is a regulatory requirement for entities listed on the ASX, providing detailed cash flow statements and financing information. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content includes actual financial data and analysis for a period shorter than a full fiscal year (a quarter), which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement of a report or a certification letter, so it is not classified as RPA or RNS. Therefore, the appropriate classification is IR (Interim / Quarterly Report). Q2 2023
2023-01-15 English
ECS Secures $9.9m Supply Agreement into Germany 2 pages 318.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 4 January 2023 from ECS Botanics Holdings Ltd. It details the execution of a binding supply agreement worth AUD 9.9 million over three years with a German medicinal cannabis company. The content focuses on a commercial contract and partnership update rather than financial results, management changes, or regulatory filings. The document is relatively short (4295 characters) and does not contain financial statements or detailed financial data. It is not an earnings release, annual report, or interim report. It is a capital/financing update related to a significant supply agreement that will impact future revenue. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-01-03 English
New Product & Market Update 2 pages 332.7KB
Capital/Financing Update Classification · 85% confidence The document is an ASX announcement dated 20 December 2022 from ECS Botanics Holdings Ltd. It provides updates on recent company activities including launching a new vaping product, first shipment to Switzerland, quarterly performance commentary, and management remarks. The content focuses on operational updates and sales growth forecasts rather than detailed financial statements or comprehensive quarterly results. The document length is 4269 characters, which is relatively short and reads like a business update or trading update rather than a full interim or quarterly report. There is no detailed financial data or analysis presented, nor is there a formal earnings release with key financial highlights. This type of document is typical of a Capital/Financing Update or a general business update announcement. Given the focus on sales growth, new product launch, and shipment news, the best fitting category is Capital/Financing Update (CAP).
2022-12-19 English
Change of Director's Interest Notice 2 pages 198.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in relevant interests in securities, including the number of shares held before and after the change, the nature of the change (on-market purchase), and dates. This type of document is a formal notification of personal share transactions by a company director. It is not a financial report, earnings release, or management discussion. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3991 characters, consistent with a concise notice rather than a full report.
2022-11-09 English
Victorian Flood Update 1 page 278.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement providing an update on flooding at ECS Botanics Holdings Ltd's facility. It discusses operational impacts, protective measures, and potential business effects but does not contain financial statements, earnings data, or detailed financial analysis. The document is relatively short (2809 characters) and serves as a situational update rather than a financial report or regulatory filing. It does not announce voting results, management changes, or capital activities. Therefore, it fits best as a general regulatory announcement about operational conditions, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2022-11-06 English
Notification of cessation of securities - ECS 4 pages 24.8KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the cessation of securities, specifically performance rights that have lapsed or expired without exercise or conversion. It details the number of securities ceased, reasons for cessation, and the updated issued capital following these changes. The document is an announcement related to changes in the company's capital structure, specifically the cessation of certain securities. It does not contain financial statements, audit information, or detailed financial results. It is not a full report but an official announcement of changes in securities. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes including cessation of securities.
2022-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.